November 03, 2025

Metastatic ER-Positive, HER2-Negative Breast Cancer: Novel Treatment Combination Improves Progression-Free Survival

Patients with ER-positive, HER2-negative advanced breast cancer showed significantly improved progression-free survival (PFS) when treated with an oral combination regimen that includes giredestrant, ...

The ASCO Post

October 31, 2025

A Young Hematologist’s Take on ICML 2025

The ASCO Post

October 31, 2025

Addition of Brentuximab Vedotin to Lenalidomide/Rituximab in Relapsed or Refractory DLBCL

The ASCO Post

November 10, 2025

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

The ASCO Post

October 30, 2025

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

The ASCO Post

October 30, 2025

Digital Histopathology and Automated Classification of Pediatric Sarcomas

The ASCO Post

The Myelofibrosis Journey From Diagnosis to Long-Term Management

This new program delivers concise, expert-informed education to guide decision-making across all stages of myelofibrosis (MF) care.

Explore the Resource

Latest Headlines

November 25, 2025

Impact of Empirical Dietary Inflammatory Pattern on Survival Outcomes in Patients With Stage III Colon Cancer

The ASCO Post

November 25, 2025

Adjuvant Use of Atezolizumab Plus Chemotherapy in DNA Mismatch Repair–Deficient Colon Cancer

The ASCO Post

November 25, 2025

Postsurgical ctDNA Testing in Stage III Colon Cancer for Treatment De-escalation

The ASCO Post

November 25, 2025

Reflections of a Medical Oncologist: Empathy Matters in Caring for Patients With Cancer

The ASCO Post

November 25, 2025

Preneoplastic and Neoplastic Small Lymphocytic Proliferations

The ASCO Post

November 25, 2025

Cognitive Function and Statin Administration During Doxorubicin-Based Cancer Treatment

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

2025 ASCO Annual Meeting

November 25, 2025

Impact of Empirical Dietary Inflammatory Pattern on Survival Outcomes in Patients With Stage III Colon Cancer

The ASCO Post

November 25, 2025

Adjuvant Use of Atezolizumab Plus Chemotherapy in DNA Mismatch Repair–Deficient Colon Cancer

The ASCO Post

June 13, 2025

Neoadjuvant Nivolumab and Chemotherapy Shows Significant OS Benefit at 5 Years in Resectable NSCLC

The ASCO Post

ESMO Congress 2025

November 25, 2025

Postsurgical ctDNA Testing in Stage III Colon Cancer for Treatment De-escalation

The ASCO Post

November 25, 2025

Pembrolizumab Plus Weekly Paclitaxel Improves Survival Outcomes in Platinum-Resistant Recurrent Ovarian Cancer

The ASCO Post

November 24, 2025

Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated NSCLC After Tyrosine Kinase Inhibitor Failure

The ASCO Post

2025 ASTRO Annual Meeting

November 25, 2025

Long-Term Survival With Stereotactic Ablative Radiotherapy vs Surgery for Early-Stage NSCLC

The ASCO Post

November 14, 2025

SABR May Be Comparable to Surgery for Early-Stage NSCLC

The ASCO Post

October 22, 2025

Biomarker-Driven Apalutamide Therapy for Patients With Recurrent Prostate Cancer

The ASCO Post

Clinical Guidelines

November 25, 2025

Adjuvant Use of Atezolizumab Plus Chemotherapy in DNA Mismatch Repair–Deficient Colon Cancer

The ASCO Post

November 25, 2025

Cognitive Function and Statin Administration During Doxorubicin-Based Cancer Treatment

The ASCO Post

November 25, 2025

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

The ASCO Post

November 25, 2025

Long-Term Survival With Stereotactic Ablative Radiotherapy vs Surgery for Early-Stage NSCLC

The ASCO Post

Commentary & Perspectives

November 25, 2025

How the Proliferation of Fraudulent Scientific Papers Is Threatening the Integrity of Cancer Research

The ASCO Post

November 25, 2025

How to Adapt to the Era of AI and the Changing Interactions With Patients: Lessons From a Low-Resource Setting

The ASCO Post

November 21, 2025

Reducing the Barriers to Receiving CAR T-Cell Therapy for Patients With Hematologic Malignancies

The ASCO Post

November 20, 2025

Realizing the Full Potential of Patient Engagement in Clinical Research

The ASCO Post

FDA & Government News

November 24, 2025

FDA Approves Pembrolizumab With Enfortumab Vedotin-ejfv for Muscle-Invasive Bladder Cancer

The ASCO Post

November 12, 2025

Longtime FDA Innovator Appointed as Director of CDER

The ASCO Post

August 29, 2023

FDA Approves Luspatercept-aamt as First-Line Treatment for Adult Patients With Lower-Risk MDS and Anemia Who May Require Transfusions

The ASCO Post

January 25, 2021

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

The ASCO Post

Business Management

November 05, 2025

How a $2 Billion Gift to the Knight Cancer Institute May Accelerate Cancer Advances and Streamline Care for Patients

The ASCO Post

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

April 10, 2025

American Cancer Society Launches CEO Search

The ASCO Post

January 29, 2025

Clinical Posters From JADPRO Live 2024

JADPRO

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

Digital Histopathology and Automated Classification of Pediatric Sarcomas

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Featured Videos

Conference Coverage

2025 ASCO Annual Meeting

ESMO Congress 2025

2025 ASTRO Annual Meeting

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management